Yüklüyor......
Notice of Compliance with Conditions: A Policy in Limbo
Since 1998, the Therapeutic Products Directorate (TPD) has had a policy termed the Notice of Compliance with conditions (NOC/c) in order to allow earlier marketing of promising drugs for serious conditions before the drugs have definitively demonstrated clinical efficacy. Drugs approved under the NO...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Longwoods Publishing
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585467/ https://ncbi.nlm.nih.gov/pubmed/19305737 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|